Cargando…

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making

Deletions of the cell cycle control gene CDKN2A are described as progression markers of non-muscle invasive bladder cancer and to be associated with fibroblast growth factor 3 (FGFR3) mutations. The prognostic role of CDKN2A RNA expression in muscle invasive bladder cancer (MIBC) is under discussion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Worst, Thomas S., Weis, Cleo-Aron, Stöhr, Robert, Bertz, Simone, Eckstein, Markus, Otto, Wolfgang, Breyer, Johannes, Hartmann, Arndt, Bolenz, Christian, Wirtz, Ralph M., Erben, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158275/ https://www.ncbi.nlm.nih.gov/pubmed/30258198 http://dx.doi.org/10.1038/s41598-018-32569-x

Ejemplares similares

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
por: Rinaldetti, Sebastien, et al.
Publicado: (2017)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
por: Sikic, Danijel, et al.
Publicado: (2020)

Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer
por: Kriegmair, M.C., et al.
Publicado: (2018)

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts
por: Sikic, Danijel, et al.
Publicado: (2019)

ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data
por: Wu, Sheng, et al.
Publicado: (2019)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2017)

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer
por: Wu, Sheng, et al.
Publicado: (2020)

mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
por: Eckstein, Markus, et al.
Publicado: (2018)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2020)

High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy
por: Eckstein, Markus, et al.
Publicado: (2020)

RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
por: Herrmann, Jonas, et al.
Publicado: (2021)

A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
por: Eckstein, Markus, et al.
Publicado: (2018)

IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status
por: Worst, Thomas S., et al.
Publicado: (2014)

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
por: Breyer, Johannes, et al.
Publicado: (2023)

KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Jütte, Hendrik, et al.
Publicado: (2021)

POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer
por: Wahby, Sarah, et al.
Publicado: (2020)

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients
por: Weyerer, Veronika, et al.
Publicado: (2021)

The EEF1A2 gene expression as risk predictor in localized prostate cancer
por: Worst, Thomas Stefan, et al.
Publicado: (2017)

Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer
por: Waldbillig, Frank, et al.
Publicado: (2020)

High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer
por: Hülsen, Sabine, et al.
Publicado: (2020)

Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
por: Breyer, Johannes, et al.
Publicado: (2017)

PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
por: Klümper, Niklas, et al.
Publicado: (2023)

Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis
por: Kubon, Jennifer, et al.
Publicado: (2020)

Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
por: Eckstein, Markus, et al.
Publicado: (2021)

Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients
por: Eckstein, Markus, et al.
Publicado: (2021)

Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7
por: Bolenz, Christian, et al.
Publicado: (2018)

CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
por: Eckstein, Markus, et al.
Publicado: (2020)

Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy
por: Taubert, Helge, et al.
Publicado: (2021)

Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
por: Weyerer, Veronika, et al.
Publicado: (2020)

A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer
por: Uysal, Daniel, et al.
Publicado: (2021)

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort
por: Weyerer, Veronika, et al.
Publicado: (2021)

Metacontrol of decision-making strategies in human aging
por: Bolenz, Florian, et al.
Publicado: (2019)

Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
por: Eckstein, Markus, et al.
Publicado: (2018)

The A148T variant of CDKN2A gene in bladder cancer
por: Borkowska, E, et al.
Publicado: (2011)

Aquaporin 3 Expression Loss in Urothelial Carcinoma: Association with Tumor Invasion Depth, but not with Grading?
por: Breyer, Johannes, et al.
Publicado: (2017)

Need for cognition does not account for individual differences in metacontrol of decision making
por: Bolenz, Florian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jbc3936urige5kq81ee36if8vd